Takhzyro 47783-0644

Generic: Lanadelumab-Flyo

Product NDC

47783-0644

Manufacturer: Takeda Pharmaceuticals America, Inc.
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: August 24, 2018
Listing Expires: December 31, 2026
Application: BLA761090

Need to source Takhzyro? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Lanadelumab	300 mg/2mL

Drug Class

Plasma Kallikrein Inhibitor [EPC]Kallikrein Inhibitors [MoA]Plasma Kallikrein Inhibitor [EPC]

Packaging Options(1)

47783-0644-01

1 VIAL, GLASS in 1 CARTON (47783-644-01) / 5 mL in 1 VIAL, GLASS

View →